IGC Pharma, Inc.
IGC Pharma, Inc. (IGC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IGC · as of Jun 9, 2026
Key Statistics
Explore IGC Pharma, Inc. Data
igc stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
igc competitorsIGC
ANTX
BOLD
INTS
ITRM
NTRBStock Performance
Full HistoryAbout IGC Pharma, Inc.
IGC Pharma, Inc. operates as a pharmaceutical firm, currently in the clinical development phase, dedicated to pioneering novel treatments for Alzheimer's, a debilitating condition. The company's pipel…
what is igc pharma, inc. · igc stock overview · igc pharma, inc. company profile · who is igc pharma, inc. ceo · igc AMEX · igc pharma, inc. headquarters · igc pharma, inc. business segments
About Stock Overview & Key Data
IGC Pharma, Inc. (IGC) is a Healthcare company in the Biotechnology industry, listed on AMEX since May 24, 2006. As of the latest trading session, IGC stock price is $0.30, with a market capitalization of $29.9M. The stock has returned -4.78% over the past 12 months and +6.25% year-to-date.
According to 2 Wall Street analysts, the consensus rating for IGC Pharma, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2026, IGC Pharma, Inc. reported revenue of $1.2M and net income of -$6.5M. For detailed data — including IGC Pharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, IGC Pharma, Inc. (IGC) stock price is $0.30. The stock is traded on AMEX under the ticker symbol IGC. The 52-week range is $0.24 – $0.50.